Back to search

Frontiers in Interventional Cardiology

Data up to Jan 2025

Published1998
Citations250
References146

Total Citations Per Year

Abstract

References (146)

A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease

1994 • 4,561 citations

A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease

1994 • 4,260 citations

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

1994 • 2,614 citations

A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery Stents

1996 • 2,032 citations

Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization

1997 • 1,922 citations

Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal Angioplasty

1987 • 1,870 citations

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

1998 • 1,395 citations

Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study

1997 • 1,346 citations

A completely biological tissue-engineered human blood vessel

1998 • 1,324 citations

Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction

1998 • 1,263 citations

Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model

1992 • 1,166 citations

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

1996 • 980 citations

A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction

1987 • 964 citations

Effects of Platelet Glycoprotein IIb/IIIa Blockade With Tirofiban on Adverse Cardiac Events in Patients With Unstable Angina or Acute Myocardial Infarction Undergoing Coronary Angioplasty

1997 • 950 citations

Matrix Metalloproteinases and Cardiovascular Disease

1995 • 873 citations

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1994 • 852 citations

Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II

1997 • 821 citations

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

1995 • 783 citations

Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular Medicine

1995 • 769 citations

A Novel Method for Nonfluoroscopic Catheter-Based Electroanatomical Mapping of the Heart

1997 • 755 citations

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

1992 • 749 citations

Angiographic Follow-up after Placement of a Self-Expanding Coronary-Artery Stent

1991 • 737 citations

Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial Infarction

1998 • 723 citations

A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease

1993 • 703 citations

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

1995 • 688 citations

THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY

1988 • 669 citations

Relationship Between Delay in Performing Direct Coronary Angioplasty and Early Clinical Outcome in Patients With Acute Myocardial Infarction

1999 • 574 citations

Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy

1993 • 549 citations

Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4

1996 • 547 citations

Endovascular Stent Design Dictates Experimental Restenosis and Thrombosis

1995 • 545 citations

Induction of Neoangiogenesis in Ischemic Myocardium by Human Growth Factors

1998 • 541 citations

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

1993 • 459 citations

Cytostatic Gene Therapy for Vascular Proliferative Disorders with a Constitutively Active form of the Retinoblastoma Gene Product

1995 • 455 citations

Initial events in interactions of blood with a foreign surface

1969 • 449 citations

Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial Injury

1994 • 443 citations

A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal Residue

1983 • 437 citations

Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine: A Review of 60 Cases

1998 • 428 citations

Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries

1996 • 404 citations

Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade With Percutaneous Coronary Intervention

1997 • 399 citations

International, Randomized, Controlled Trial of Lamifiban (a Platelet Glycoprotein IIb/IIIa Inhibitor), Heparin, or Both in Unstable Angina

1998 • 391 citations

Gene therapy inhibiting neointimal vascular lesion

1995 • 387 citations

Significance of Mild Transient Release of Creatine Kinase–MB Fraction After Percutaneous Coronary Interventions

1996 • 383 citations

Nonfluoroscopic, in vivo navigation and mapping technology

1996 • 380 citations

Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: Clinical and angiographic outcomes

1993 • 371 citations

Immediate vs Delayed Catheterization and Angioplasty Following Thrombolytic Therapy for Acute Myocardial Infarction

1988 • 358 citations

Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction

1998 • 336 citations

Seeding of intravascular stents with genetically engineered endothelial cells.

1989 • 328 citations

Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart

1998 • 320 citations

Transmyocardial laser revascularization: Results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease

1997 • 317 citations

Regulation of Vascular Smooth Muscle Cell Migration and Proliferation In Vitro and in Injured Rat Arteries by a Synthetic Matrix Metalloproteinase Inhibitor

1996 • 311 citations

Inhibition of Matrix Metalloproteinase Activity Inhibits Smooth Muscle Cell Migration but Not Neointimal Thickening After Arterial Injury

1996 • 307 citations

Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial

2001 • 304 citations

Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.

1994 • 290 citations

A Randomized Comparison of Combined Ticlopidine and Aspirin Therapy Versus Aspirin Therapy Alone After Successful Intravascular Ultrasound–Guided Stent Implantation

1996 • 287 citations

Prognostic Implication of Creatine Kinase Elevation Following Elective Coronary Artery Interventions

1997 • 278 citations

Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.

1997 • 273 citations

Toward a New Frontier in Myocardial Reperfusion Therapy

1998 • 264 citations

Continued benefit of coronary stenting versus balloon angioplasty: One-year clinical follow-up of Benestent trial

1996 • 261 citations

The electrochemical behavior of metallic implant materials as an indicator of their biocompatibility

1987 • 261 citations

Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.

1994 • 250 citations

Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury.

1994 • 245 citations

Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor.

1996 • 243 citations

Human Endothelial Nitric Oxide Synthase Gene Transfer Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation After Balloon Injury in Rats

1998 • 240 citations

Transmyocardial laser revascularization: Clinical experience with twelve-month follow-up

1996 • 237 citations

Low-Dose Radioactive Endovascular Stents Prevent Smooth Muscle Cell Proliferation and Neointimal Hyperplasia in Rabbits

1995 • 223 citations

Transmyocardial laser revascularization: Operative techniques and clinical results at two years

1996 • 221 citations

Arterial Gene Therapy for Therapeutic Angiogenesis in Patients With Peripheral Artery Disease

1995 • 216 citations

Subacute stent thrombosis: Evolving issues and current concepts

1996 • 211 citations

Adenovirus-Mediated Gene Transfer of the Human TIMP-1 Gene Inhibits Smooth Muscle Cell Migration and Neointimal Formation in Human Saphenous Vein

1998 • 196 citations

Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation

1992 • 190 citations

Reduction in Thrombotic Events With Heparin-Coated Palmaz-Schatz Stents in Normal Porcine Coronary Arteries

1996 • 188 citations

Thrombosis of a flexible coil coronary stent: Frequency, predictors and clinical outcome

1993 • 180 citations

Transmyocardial laser revascularization. Anatomic evidence of long-term channel patency.

1994 • 171 citations

Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro.

1992 • 171 citations

Outpatient Coronary Stent Implantation

1997 • 171 citations

Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries

1994 • 160 citations

Local adenoviral–mediated expression of recombinant hirudin reduces neointima formation after arterial injury

1996 • 159 citations

Inhibition of Neointimal Proliferation With Low-Dose Irradiation From a β-Particle–Emitting Stent

1996 • 158 citations

Restoration of Coronary Flow in Myocardial Infarction by Intravenous Chimeric 7E3 Antibody Without Exogenous Plasminogen Activators

1997 • 152 citations

The Myth of the Myocardial ‘Infarctlet’ During Percutaneous Coronary Revascularization Procedures

1996 • 140 citations

Pure β-ParticleEmitting Stents Inhibit Neointima Formation in Rabbits

1996 • 132 citations

Relative risk analysis of angiographic predictors of restenosis within the coronary Wallstent.

1991 • 129 citations

Effects of Endovascular Radiation From a β-Particle–Emitting Stent in a Porcine Coronary Restenosis Model

1996 • 128 citations

Low-dose, beta-particle emission from 'stent' wire results in complete, localized inhibition of smooth muscle cell proliferation.

1994 • 126 citations

Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model.

1994 • 120 citations

Suppression of Neointimal Smooth Muscle Cell Accumulation in Vivo by Antisense cdc2 and cdk2 Oligonucleotides in Rat Carotid Artery

1994 • 116 citations

Paired Comparison of Vascular Wall Reactions to Palmaz Stents, Strecker Tantalum Stents, and Wallstents in Canine Iliac and Femoral Arteries

1996 • 112 citations

Polymeric stenting in the porcine coronary artery model: Differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents

1994 • 109 citations

c- myc in Vasculoproliferative Disease

1995 • 108 citations

A Call for Provisional Stenting

1998 • 102 citations

Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary palmaz-schatz stenting

1996 • 102 citations

Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro.

1992 • 97 citations

Structure-Function Relationships in the Tissue Inhibitors of Metalloproteinases

1994 • 95 citations

Angiogenesis in transmyocardial laser revascularization. A nonspecific response to injury.

1998 • 94 citations

One-month histologic response of transmyocardial laser channels with molecular intervention

1996 • 94 citations

Abciximab Therapy and Unplanned Coronary Stent Deployment

1998 • 92 citations

Clinical report: Laser myocardial revascularization

1986 • 88 citations

Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis

1996 • 86 citations

Investigation of three‐surface properties of several metals and their relation to blood compatibility

1972 • 85 citations

Coronary stenting with a new, radiopaque, balloon-expandable endoprosthesis in pigs.

1991 • 81 citations

A novel strategy for stent deployment in the treatment of acute or threatened closure complicating ballon coronary angioplasty

1993 • 79 citations

Influence of surface texture and charge on the biocompatibility of endovascular stents.

1995 • 79 citations

Antithrombotic Potential of Polymer-Coated Stents Eluting Platelet Glycoprotein IIb/IIIa Receptor Antibody

1996 • 77 citations

Endothelialization of Intravascular Stents

1988 • 75 citations

Subacute Thrombosis and Vascular Injury Resulting From Slotted-Tube Nitinol and Stainless Steel Stents in a Rabbit Carotid Artery Model

1996 • 75 citations

Subacute Stent Thrombosis and the Anticoagulation Controversy: Changes in Drug Therapy, Operator Technique, and the Impact of Intravascular Ultrasound

1996 • 73 citations

Biocompatibility of polyurethane-coated stents: Tissue and vascular aspects

1998 • 67 citations

Effects of design geometry of intravascular endoprostheses on stenosis rate in normal rabbits

1992 • 64 citations

Stent-induced Intimal Hyperplasia: Are There Fundamental Differences between Flexible and Rigid Stent Designs?

1994 • 63 citations

Seeding of intracoronary stents with immortalized human microvascular endothelial cells

1995 • 55 citations

Results of intracoronary recombinant human vascular endothelial growth factor (rhVEGF) administration trial

1998 • 49 citations

The Beta-Particle—Emitting Radioisotope Stent (Isostent): Animal Studies and Planned Clinical Trials

1996 • 48 citations

Measurement of myocardial blood flow using positron emission tomography before and after transmyocardial revascularization

1998 • 44 citations

Comparison of the thrombogenicity of stainless steel and tantalum coronary stents

1995 • 44 citations

The importance of adequate anticoagulation to prevent early thrombosis after stenting of stenosed venous bypass grafts

1991 • 43 citations

Effect of local delivery of heparin and methotrexate on neointimal proliferation in stented porcine coronary arteries

1992 • 39 citations

Acute and chronic effects of self-expanding nitinol stents in porcine coronary arteries

1997 • 37 citations

The Antiatherogenic Effect of Iridium192 upon the Cholesterolfed Rabbit*

1964 • 34 citations

Biodegradable Stents: The Future of Interventional Cardiology?

1995 • 33 citations

In the blood: proposed new requirements for registering generic drugs

1998 • 32 citations

Mechanical features of the duke biodegradable intravascular stent

1991 • 32 citations

Arterial autologous graft-stent for treatment of coronary artery disease: A new technique

1997 • 26 citations

Composition of Human Thrombus Assessed by Quantitative Colorimetric Angioscopic Analysis

1997 • 20 citations

Neointimal fibrosis in vascular pathologies: role of growth factors and metalloproteinases in vascular smooth muscle proliferation.

1995 • 19 citations

Relation of thrombotic occlusion of coronary stents to the indication for stenting, stent size, and anticoagulation

1995 • 19 citations

Metallic Surface Treatment Using Electrochemical Polishing Decreases Thrombogenicity and Neointimal Hyperplasia After Coronary Stent Implantation in a Porcine Model

1998 • 18 citations

Integrelin for emergency coronary artery stenting

1996 • 16 citations

Neointima Formation in Injured Hamster Carotid Artery Is Effectively Prevented by the Combination G4120 and Quinapril

1996 • 15 citations

Metallic surface treatment using electrochemical polishing decreases thrombogenicity and neointimal hyperplasia after coronary stent implantation in a porcine model

1998 • 13 citations

Bioabsorbable, Drug-Eluting, Intracoronary Stents: Design and Future Applications

1992 • 12 citations

Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention

1998 • 9 citations

In-vitro thrombus formation of stent wires: Role of metallic composition and heparin coating

1991 • 9 citations

1001-29 Prevention of Subacute Stent Thrombosis by Polymer-Polyethylene Oxide-Heparin Coating in the Rabbit Carotid Artery

1995 • 8 citations

Autologous vein graft-coated stent for the treatment of coronary artery disease: Immediate results after percutaneous implantation in humans

1996 • 6 citations

Feasibility study of percutaneous transluminal myocardial revascularization (PTMR) with a Holmium laser and fiberoptic delivery system

1998 • 5 citations

Local perivascular basic fibroblast growth factor (bFGF) treatment in patients with ischemic heart disease

1998 • 4 citations

Multicenter aspirin and ticlopidine trial after intracoronary stenting in high risk patients

1998 • 4 citations

793-4 Local Delivery of C-myb Antisense attenuates Neo-Intimal Thickening in a Porcine Model of Coronary Angioplasty

1995 • 4 citations

Stents Coated by an Autologous Arterial Graft: The First Application in Human Coronary Arteries

1998 • 3 citations

Percutaneous transluminal myocardial revacularization (PTMR): procedural results and early clinical outcome

1998 • 3 citations

967-20 Reduced Thrombogenicity of Nitinol vs Stainless Steel Slotted-Tube Stents in Rabbit Carotid Arteries

1995 • 3 citations

Primary autologous vein graft-coated stent in acute myocardial infarction : Immediate and short-term results

1996 • 2 citations

Stents coated by an autologous arterial graft: the first application in human coronary arteries

1998 • 2 citations

Transmyocardial laser revascularization increases dobutamine-induced angina threshold in patients with refractory angina

1998 • 1 citations

The impact of laser transmyocardial revascularization on indices of ventricular repolarization

1998 • 1 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...